Breathe Well Live Well
 Zee News |
Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drug
Economic Times NEW DELHI: Drug firms Aurobindo Pharma and Glenmark today said they have received approval from the US health regulator to manufacture and market generic montelukast sodium tablets used for treating asthma and allergies. Both the companies said … Pharma cos set to gain from US nod for asthma drug |
View full post on asthma – Google News
|
Glenmark gets final US FDA nod for asthma treatment drug
Moneycontrol.com … has received final approval from US Food and Drugs Administration for its abbreviated new drug application (ANDA) to market Montelukast Sodium tablets in 10 mg strength, which are used for the treatment for prophylaxis and chronic treatment of asthma. |
View full post on asthma – Google News
|
Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA …
Economic Times NEW DELHI: Indian drug makers, including Aurobindo and Glenmark, are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. Last week the US Food and Drug … |
View full post on asthma – Google News
|
Glenmark gets FDA tentative nod for anti-asthma tablets
Moneylife Personal Finance site and magazine Glenmark Pharmaceuticals said it has received tentative approval from the US health regulator to market its generic Montelukast Sodium tablets used for treating asthma and seasonal allergies. Glenmark Generics Inc has received tentative approval from … |
View full post on asthma – Google News
 Moneycontrol.com |
Glenmark Pharmaceuticals receives USFDA tentative nod for anti-asthma tablets
Economic Times NEW DELHI: Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator to market its generic Montelukast Sodium tablets used for treating asthma and seasonal allergies. Glenmark Generics Inc has received … Glenmark gets tentative US FDA nod for asthma drug Glenmark Generics gets Tentative USFDA nod for Montelukast Sodium 10 mg tablets |
View full post on asthma – Google News
 Moneycontrol.com |
Glenmark starts Revamilast Phase IIb trials
Pharmaceutical Business Review Indian drug maker Glenmark Pharmaceuticals has started Phase IIb trials to evaluate Revamilast (GRC 4039) as a treatment for inflammatory disorders like rheumatoid arthritis (RA) and asthma. The trials aim to determine the safety and efficacy profile … Glenmark starts Phase-IIb human trials of Revamilast molecule Glenmark starts phase IIb human trials of molecule Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule … |
View full post on asthma – Google News
Moneycontrol.com |
Glenmark starts phase IIb human trials of molecule
mydigitalfc.com Glenmark is positioning Revlimast as a treatment for chronic inflammatory disorders such as asthma and rheumatoid arthritis. Rheumatoid arthritis and asthma drugs are estimated to have a market in excess of $20 billion each. … Glenmark starts Phase-IIb human trials of Revamilast molecule Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule … |
View full post on asthma – Google News
|
Glenmark starts Phase-IIb human trials of Revamilast molecule
Economic Times NEW DELHI: Glenmark Pharmaceuticals on Wednesday said it has started Phase-IIb human trials of its 'Revamilast' molecule, which is being developed for treatment of inflammatory disorders like asthma and rheumatoid arthritis. The Phase-IIb studies of … Glenmark initiates Phase IIb human trials globally for its novel molecule … |
View full post on asthma – Google News